Trial · NCT07801833
Executive Function Training Program for Children With ASD
NCT07801833, Not applicable, Active not recruiting, Seoul National University Bundang Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Executive Function Training Program for Children With ASD. Trials, record NCT07801833. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07801833
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Executive Function Training Program for Children With ASD
- NCT number
- NCT07801833
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- Seoul National University Bundang Hospital
- Conditions
- Autism Spectrum Disorder
- Interventions
- Executive Function Training Program
- First posted
- 2026-09-03
- Last updated
- 2026-09-03
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Executive Function as Assessed by the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The BRIEF-2 is a parent-report questionnaire that assesses executive function behaviors in children's everyday life. The Global Executive Composite (GEC), index scores, and individual clinical scale scores will be analyzed to evaluate changes in different aspects of executive functioning. Higher T-scores indicate greater difficulties with executive functioning, whereas lower T-scores indicate fewer difficulties. |
| Secondary | Adaptive Behavior as Assessed by the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The Vineland-3 is a standardized measure of adaptive functioning in everyday life. The Adaptive Behavior Composite (ABC) score will be used as the primary outcome measure. Domain scores for Communication, Daily Living Skills, and Socialization will also be analyzed. Higher scores indicate better adaptive functioning. |
| Secondary | Emotion Regulation as Assessed by the Emotion Regulation Checklist (ERC) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The Emotion Regulation Checklist (ERC) is a 24-item questionnaire that assesses children's emotional regulation and emotional lability/negativity. Items are rated on a 4-point scale from 1 (Never) to 4 (Always). Scores for the Emotion Regulation and Lability/Negativity subscales will be analyzed, with higher Emotion Regulation scores indicating better emotion regulation and higher Lability/Negativity scores indicating greater emotional dysregulation. |
| Secondary | Academic Self-Regulation as Assessed by the Academic Self-Regulation Questionnaire (SRQ-A) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The Academic Self-Regulation Questionnaire (SRQ-A) is a child-report measure that assesses children's reasons for engaging in school-related behaviors. It includes four regulatory styles: external regulation, introjected regulation, identified regulation, and intrinsic motivation. Items are rated on a 4-point scale, with higher subscale scores indicating greater endorsement of the corresponding regulatory style. Subscale scores and the Relative Autonomy Index (RAI) will be analyzed, with higher RAI scores indicating more autonomous or self-determined regulation. |
| Secondary | Prosocial Self-Regulation as Assessed by the Prosocial Self-Regulation Questionnaire (SRQ-P) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The Prosocial Self-Regulation Questionnaire (SRQ-P) is a child-report measure that assesses children's reasons for engaging in prosocial behaviors. It includes three regulatory styles: external regulation, introjected regulation, and identified regulation. Items are rated on a 4-point scale, with higher subscale scores indicating greater endorsement of the corresponding regulatory style. Subscale scores will be analyzed to assess changes in the regulation of prosocial behavior. |
| Other | Inhibitory Control as Assessed by the Stroop Test | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The Stroop Test is a performance-based measure used to assess inhibitory control and cognitive interference. Performance indices derived from the Stroop task will be analyzed, with better performance reflecting greater inhibitory control and ability to manage cognitive interference. |
| Other | Cognitive Flexibility as Assessed by the Children's Color Trails Test (CCTT) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The CCTT is a performance-based measure of attention, sequencing, and cognitive flexibility in children. Performance indices from the CCTT will be analyzed to assess changes in attentional control and cognitive flexibility, including the ability to shift between task demands. |
| Other | Cognitive Flexibility as Assessed by the Wisconsin Card Sorting Test (WCST) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The WCST is a performance-based measure of executive functioning that assesses cognitive flexibility, concept formation, and the ability to shift cognitive sets in response to changing feedback. Performance indices from the WCST will be analyzed to assess changes in cognitive flexibility. |
| Other | Autism-Related Social Functioning as Assessed by the Social Responsiveness Scale, Second Edition (SRS-2) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | The SRS-2 is a questionnaire that assesses social functioning and autism-related social difficulties. Total and subscale scores will be analyzed. Higher scores indicate greater difficulties in social functioning and greater severity of autism-related social characteristics. |
| Other | Emotional and Behavioral Problems as Assessed by the Child Behavior Checklist (CBCL) | Baseline, immediately after the 12-week intervention, and 12 weeks after completion of the intervention | Description: range of emotional and behavioral problems in children. Composite and syndrome scale scores will be analyzed. Higher scores indicate greater emotional and behavioral difficulties. |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Card Sorting Test (Berg) | Other outcome | ConductCognition |
| Stroop Color-Word Test | Other outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07801833
GET https://conductscience.org/api/trials/v1/NCT07801833/registered